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Abstract: mpairments in central reward processing constitute an important aspect of the negative
symptoms of schizophrenia. Despite its clinical relevance, the etiology of deficient reward processing
in schizophrenia remains largely unknown. Here, we used an epidemiologically informed mouse model of
schizophrenia to explore the effects of prenatal immune activation on reward-related functions. The model
is based on maternal administration of the viral mimic PolyI:C and has been developed in relation to the
epidemiological evidence demonstrating enhanced risk of schizophrenia and related disorders following
prenatal maternal infection. We show that prenatal immune activation induces selective deficits in the
expression (but not acquisition) of conditioned place preference for a natural reward (sucrose) without
changing hedonic or neophobic responses to the reward. On the other hand, prenatal immune activation
led to enhanced place preference for the psychostimulant drug cocaine, while it attenuated the locomotor
reaction to the drug. The prenatal exposure did not alter negative reinforcement learning as assessed
using a contextual fear conditioning paradigm. Our findings suggest that the nature of reward-related
abnormalities following prenatal immune challenge depends on the specificity of the reward (natural re-
ward vs drug of abuse) as well as on the valence domain (positive vs negative reinforcement learning).
Moreover, our data indicate that reward abnormalities emerging in prenatally immune-challenged off-
spring may, at least in part, stem from an inability to retrieve previously established context-reward
associations and to integrate such information for appropriate goal-directed behavior.
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Abnormal context–reward associations in an immune-
mediated neurodevelopmental mouse model with relevance to
schizophrenia
MA Labouesse1, W Langhans1 and U Meyer1,2
Impairments in central reward processing constitute an important aspect of the negative symptoms of schizophrenia. Despite its
clinical relevance, the etiology of deﬁcient reward processing in schizophrenia remains largely unknown. Here, we used an
epidemiologically informed mouse model of schizophrenia to explore the effects of prenatal immune activation on reward-related
functions. The model is based on maternal administration of the viral mimic PolyI:C and has been developed in relation to the
epidemiological evidence demonstrating enhanced risk of schizophrenia and related disorders following prenatal maternal
infection. We show that prenatal immune activation induces selective deﬁcits in the expression (but not acquisition) of conditioned
place preference for a natural reward (sucrose) without changing hedonic or neophobic responses to the reward. On the other
hand, prenatal immune activation led to enhanced place preference for the psychostimulant drug cocaine, while it attenuated the
locomotor reaction to the drug. The prenatal exposure did not alter negative reinforcement learning as assessed using a contextual
fear conditioning paradigm. Our ﬁndings suggest that the nature of reward-related abnormalities following prenatal immune
challenge depends on the speciﬁcity of the reward (natural reward vs drug of abuse) as well as on the valence domain (positive vs
negative reinforcement learning). Moreover, our data indicate that reward abnormalities emerging in prenatally immune-
challenged offspring may, at least in part, stem from an inability to retrieve previously established context–reward associations and
to integrate such information for appropriate goal-directed behavior.
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INTRODUCTION
Schizophrenia is a chronic neuropsychiatric disease characterized
by multiple and often co-existing psychopathological symptoms,
which are typically referred to as positive, negative and cognitive
symptoms.1 Positive symptoms include visual and/or auditory
hallucinations, delusions, paranoia and major thought disorders,
whereas the cognitive symptoms of schizophrenia involve
disturbances in executive functions, working memory impairment
and inability to sustain attention. Negative symptoms represent a
class of deﬁcits in the emotional and behavioral domains, which
include asociality, poverty of speech, blunted affect and a number
of distinct impairments in reward processing.2
Abnormalities in central reward processing are a cluster of
motivational and behavioral deﬁcits that remain largely
unresponsive to currently available antipsychotic drugs and can
strongly undermine the daily life quality of affected individuals.3–5
They include impairments in positive reinforcement learning,
attribution of incentive motivation, effort-value computations and
translation of reward-related information into goal-directed
behavior.6,7 On the other hand, the ability to enjoy pleasant
stimuli seems to be largely intact in patients with schizophrenia,
suggesting that schizophrenia-associated reward abnormalities
emerge in the absence of anhedonia.8 Instead, reward-related
deﬁcits in this population may primarily stem from difﬁculties in
using internal representations of previous rewarding experiences
to drive goal-directed behaviors, which in turn would allow
obtaining the desired outcomes.6,9–11 These impairments seem to
be restricted to positive reinforcement learning, whereas negative
reinforcement or aversive learning appears to be largely intact in
individuals with schizophrenia.12,13
In addition to the difﬁculties in treating reward deﬁciencies, the
underlying etiological mechanisms also remain largely elusive.
Although antipsychotic drugs can affect reward-related functions,9
this class of symptoms has also been documented in unmedicated
patients with schizophrenia.14 At least some of the reward
abnormalities in schizophrenia may thus have a developmental
origin and early onset.15 Yet, the genetic and environmental risk
factors of these deﬁcits remain largely unknown. We therefore
explored whether schizophrenia-relevant abnormalities in central
reward processing may be induced by prenatal exposure to
infection, which has been repeatedly implicated in the etiology of
schizophrenia and other neurodevelopmental disorders.16,17
For this purpose, we used a well-established mouse model of
maternal immune activation by the viral mimic polyriboinosinic–
polyribocytidilic acid (PolyI:C).18 Numerous previous investigations
have provided robust evidence for the emergence of long-term
functional and structural brain abnormalities following prenatal
exposure to PolyI:C, many of which are implicated in schizo-
phrenia and related disorders.18,19 At least some of the behavioral
and cognitive abnormalities can be normalized by antipsychotic
drug administration20–22 and emerge as a function of post-
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pubertal maturational processes.21–25 Hence, the prenatal PolyI:C
administration model in rodents is characterized by substantial
face, construct and predictive validity, and it bares epidemiological
relevance to schizophrenia and related disorders. As with many
other preclinical models of schizophrenia, however, the PolyI:C
model has thus far only received scant attention with respect to
modeling deﬁcits relevant to the negative symptoms of
schizophrenia.26,27 Extending the behavioral characterization of
the model to reward-related functions is thus expected to provide
novel information with regard to etiological processes underlying
the emergence of deﬁcits pertinent to the negative symptoms.
Recent investigations in animal models of schizophrenia have
largely focused on incentive motivation abnormalities that
associate with reduced exertion of effort.28,29 Because patients
with schizophrenia exhibit impairments in other distinct neuro-
psychological processes that are independent of effort-related
behavior, such as for example positive reinforcement learning or
reward-based decision making,9–12 we focused our attention on
Pavlovian-based tests that require only minimal levels of effort
exertion. We explored the effects of prenatal PolyI:C-induced
immune challenge on Pavlovian-based reward behaviors using a
well-established contextual reward conditioning task, namely the
conditioned place preference (CPP) test.30 Performance in the CPP
test is dependent on various hippocampal and cortico-striatal
circuits,31 which are known to be altered in schizophrenia.31–35
Using the CPP test, we evaluated context–reward associations
using a natural reward (sucrose) and the psychostimulant drug
cocaine. We also assessed the effects of prenatal immune
Figure 1. Prenatal immune activation impaired context–reward associations elicited by natural sucrose reward. (a) Reduced place preference
for sucrose in offspring born to PolyI:C-exposed (POL) mothers as compared with control (CON) mothers. The line plots show exploratory time
in the water-paired (W) and sucrose-paired (S) chambers as a function of 5-min bins during the test phase, and the bar plots show the total
exploratory time in the two chambers across the entire test period. *Po0.05, based on post hoc comparisons. (b) Reduced place preference for
sucrose in POL offspring as assessed by the relative difference in the time spent in the sucrose- vs water-paired chamber. #Po0.05, based on a
Mann–Whitney test. (c) Intact locomotor activity in POL and CON offspring during the place preference test phase. The line plots show the
log-transformed distance moved in both chambers as a function of 5-min bins during the test phase, and the bar plots show the distance
moved across the entire test period. (d) Computer-generated exploration patterns for representative POL and CON offspring in the two
(water- or sucrose-paired) chambers during the test phase. (e) Intact locomotor activity in POL and CON offspring during the conditioning
phase of the test. The line plots show the total distance moved in the water- and sucrose-paired chambers on conditioning days 1–4. (f) Intact
log-transformed latency to consume sucrose in the sucrose-paired chamber on the last conditioning day in POL and CON offspring.
N(CON)= 35, N(POL)= 35. All values are mean± s.e.m.
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activation on hedonic and neophobic responses to natural sucrose
reward in attempts to identify possible relationships between
positive reinforcement learning and anhedonic and/or neophobic
behavior. Finally, we used a contextual fear conditioning paradigm
to explore the effects of prenatal immune activation on negative
reinforcement learning that involves contextual processing of
aversive events.
MATERIALS AND METHODS
Maternal immune activation during pregnancy
C57BL6/N pregnant dams on gestation day 17 were randomly assigned to
receiving either PolyI:C (potassium salt; Sigma-Aldrich, Buchs, Switzerland)
or vehicle (NaCl). Adult offspring born to immune-challenged and control
mothers were included in the study. All procedures had been previously
approved by the Cantonal Veterinarian's Ofﬁce of Zurich and are fully
described in the Supplementary Methods.
Behavioral characterization of offspring born to
immune-challenged and control mothers
We evaluated positive contextual conditioning for sucrose and cocaine
using standard CPP paradigms.30,36 In addition, we evaluated whether
anhedonic behavior and anxiety-related sucrose neophobia could
represent confounders inﬂuencing the behavioral responses in the sucrose
CPP. Finally, to explore the effects of prenatal immune activation on
negative contextual conditioning, we measured context–fear-associative
learning using a standard contextual fear conditioning paradigm.37 The
behavioral paradigms are fully described in the Supplementary Methods.
Statistical analyses
All data met the assumptions of normal distribution and equality of
variance, or were transformed accordingly. All data were analyzed using
Student’s t-tests (two tailed), parametric analysis of variance or analysis of
covariance, followed by Fisher's least signiﬁcant difference post hoc group
comparisons, or non-parametric Mann–Whitney tests. Statistical analyses
are fully described in the Supplementary Methods.
RESULTS
Prenatal immune activation reduces contextual conditioning for
sucrose reward
In a ﬁrst series of investigations, we explored the effects of
prenatal immune activation on contextual appetitive conditioning
for sucrose using a standard sucrose CPP test. Following
conditioning, the exploration time between the sucrose-paired
and the water-paired (control) chamber was used to assess
contextual appetitive conditioning in adult control and PolyI:C
offspring. The exploration time was recorded during a 25-min test
period and analyzed as a function of 5-min bins. As shown in
Figure 1a, control offspring displayed a clear preference toward
the sucrose-paired chamber, indicating intact contextual appeti-
tive conditioning. This preference was fully abolished in PolyI:C
offspring, so that they persistently explored both chambers to a
similar extent during the entire test session (Figure 1a). Statistical
support for these observations was obtained by the signiﬁcant
interaction between chamber and prenatal treatment
(F(1,68) = 4.51, Po0.05) and by the subsequent restricted analyses
of variance revealing a signiﬁcant difference between the sucrose-
paired and the water-paired chambers in control (F(1,34) = 5.78,
Po0.05), but not in PolyI:C offspring (Figure 1b). Similar results
were obtained when sucrose CPP was indexed by the relative
difference in the time spent in the sucrose- vs water-paired
chamber (Figure 1b). These analyses revealed that control
offspring spent ~ 120 s more in the sucrose-paired chamber than
in the water-paired chamber, whereas PolyI:C offspring spent
~ 40 s less in the sucrose chamber relative to the water chamber
(Figure 1b). This led to a signiﬁcant group difference (Mann–
Whitney test: Z=− 2.091, Po0.05) in the relative time spent in the
sucrose- vs water-paired chamber. Representative exploration
patterns of PolyI:C and control offspring can be found in Figure 1d.
Notably, the effects of prenatal immune activation on sucrose
CPP emerged in the absence of any difference in general
locomotor activity during the test session (Figure 1c) or during
the conditioning sessions (Figure 1e). These effects also emerged
independently of any differences in general food or ﬂuid intake
measured in the same cohort of animals (data not shown),
supporting the notion that differences in hunger or thirst did not
affect the behavioral readouts of interest. We also assessed the
strength of appetitive conditioning by measuring the latencies to
consume the sucrose solution on the last conditioning day. This
analysis revealed highly similar latencies in control and PolyI:C
offspring, with the majority (~90%) of animals starting to consume
the sucrose reward within the ﬁrst 80 s (see Figure 1f showing the
log-transformed latency to drink on the last conditioning day).
None of the animals consumed water in the water-paired chamber
within the ﬁrst 5 min of the last conditioning session (data not
shown). Together these results suggest that prenatal immune
activation leads to abnormalities in contextual appetitive con-
ditioning for natural sucrose reward in the absence of possible
confounding effects on locomotor activity and/or deﬁcits in
appetitive conditioning per se.
Prenatal immune activation does not affect hedonic or neophobic
responses to sucrose
Next, we evaluated whether the PolyI:C-induced deﬁcits in CPP for
sucrose may be associated with anhedonic behavior toward the
primary reinforcer, that is, an inability to experience pleasure from
stimuli that others normally ﬁnd pleasurable. To this end, we
compared control and PolyI:C animals in a two-bottle sucrose
preference test, which is frequently used to assess anhedonic
behavior.38 We used the same 30% sucrose solution as in the
preceding CPP test so as to provide a direct comparison between
the two experimental paradigms. As shown in Figure 2a, PolyI:C
and control offspring similarly displayed a marked (~95%)
preference toward the sucrose solution, indicating intact hedonic
reactions to the reinforcer in both prenatal treatment groups.
Likewise, total ﬂuid (water and sucrose solution) intake was also
highly comparable between PolyI:C and control offspring during
the entire 24-h test (Figure 2b).
Figure 2. Prenatal immune activation did not affect sucrose
preference or sucrose neophobia. (a) Intact sucrose preference in
offspring born to PolyI:C-exposed (POL) or control (CON) mothers as
indexed by the percentage score [sucrose consumption/(total liquid
consumption) × 100%] obtained during a 24-h test period using a
30% sucrose solution; N(CON)= 8, N(POL)= 8. (b) Intact total ﬂuid
(water+sucrose solution) consumption during the 24-h sucrose
preference test period. (c) Intact sucrose neophobia in POL and CON
offspring as assessed by the latency to start consuming sucrose
solution (30% sucrose) upon its ﬁrst presentation. N(CON)= 8,
N(POL)= 8. All values are mean± s.e.m.
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We further explored whether PolyI:C offspring might show
altered neophobic responses to the same 30% sucrose solution. In
this test, sucrose neophobia was indexed by the latency to start
consuming sucrose solution when presented the ﬁrst time in a
familiar context. These analyses revealed no signiﬁcant group
differences (Figure 2c), indicating intact neophobic reaction to the
sucrose reinforcer in both prenatal treatment groups.
Prenatal immune activation does not affect aversive contextual
conditioning
Given that prenatal immune challenge robustly affected the
expression of positive contextual conditioning (Figure 1), we next
sought to explore whether deﬁcits in contextual learning would
extend to the negative valence domain. We thus subjected PolyI:C
and control offspring to a contextual fear conditioning task,
whereby the acquisition and expression of contextual fear was
indexed by the percent time freezing.
During the conditioning phase of the contextual fear test, the
amount of percent time freezing generally increased across the
three successive post-shock periods (Figure 3a), indicating that the
animals developed a noticeable fear response as a result of shock
exposure. The development of such fear responses was highly
comparable between the experimental groups (Figure 3a). Hence,
prenatal immune activation did not signiﬁcantly affect the
acquisition of contextual fear. Contextual fear memory was then
evaluated 24 h following conditioning and was indexed by the
expression of conditioned fear toward the context, in which
aversive conditioning took place. Again, PolyI:C and control
offspring displayed comparable levels of conditioned fear toward
the context (Figure 3b), suggesting that prenatal immune
activation did not affect the retention of previously acquired
contextual fear memories. These data demonstrate that prenatal
immune activation does not alter contextual learning belonging to
the negative valence domain, despite the fact that it impaired
positive contextual conditioning for sucrose reward (Figure 1).
Prenatal immune activation enhances contextual conditioning for
cocaine reward
Finally, we explored whether prenatal immune activation would
alter contextual reward learning under conditions in which the
reward takes the form of the psychostimulant drug cocaine. To
this end, PolyI:C and control offspring were subjected to a CPP for
cocaine, and the exploration time between the cocaine- and
saline-paired chambers was used to index contextual conditioning
for cocaine. As expected,36 conditioning led to a robust preference
for the cocaine-paired chamber in both prenatal treatment
groups, whereby the time spent in the cocaine-paired chamber
was signiﬁcantly higher than the time spent in the saline-paired
chamber (main effect of drug: F(1,34) = 55.29, Po0.001) (Figure 4a).
Interestingly, prenatal immune activation potentiated this effect,
so that the exploration time in the cocaine-paired chamber was
longer in PolyI:C offspring compared with controls. This was
reﬂected by the signiﬁcant interaction between chamber and
prenatal treatment (F(1,34) = 5.48, Po0.05) and by the signiﬁcant
difference in the exploration time of cocaine- and saline-paired
chambers between the two prenatal treatment groups
(F(1,34) = 5.48, Po0.05) revealed in subsequent restricted analyses
of variance (Figure 4a). Similar results were obtained when cocaine
CPP was indexed by the relative difference in the time spent in the
cocaine- vs saline-paired chamber (Figure 4b): although control
offspring spent ~ 300 s more in the cocaine-paired chamber than
in the saline-paired chamber, PolyI:C offspring spent twice the
amount of time (~600 s) in the cocaine-paired chamber as
compared with the saline-paired chamber, leading to a signiﬁcant
prenatal group difference (F(1,34) = 5.48, Po0.05). These analyses
remained signiﬁcant after inclusion of locomotor activity as
covariates in an analysis of covariance (day 1 included as a
covariate: F(2,33) = 4.63, Po0.01; day 2 included as a covariate:
F(2,33) = 4.21, Po0.01). Prenatal treatment did not affect general
locomotor activity, as indexed by the total distance moved on the
test day (Figure 4c). Representative exploration patterns of PolyI:C
and control offspring can be found in Figure 4d.
Aberrant expression of cocaine-associated place preference
could emerge as a consequence of altered cocaine sensitivity. To
explore this possibility, we analyzed the locomotor responses to
cocaine administration during the conditioning sessions. As
expected, cocaine administration increased locomotor activity
compared with saline treatment (main effect of drug
(F(1,34) = 81.38, Po0.001) in square-root-transformed data). Sub-
sequent a priori separation of cocaine and saline data revealed
that the cocaine-induced enhancement of locomotor activity was
apparent in both experimental groups. This locomotor-stimulating
effect of cocaine was, however, blunted in PolyI:C offspring
compared with controls, especially within the ﬁrst 15 min after
drug injection (Figure 4e). These observations were supported by
the presence of a signiﬁcant main effect of prenatal treatment
(F(1,34) = 4.33, Po0.05) and by a signiﬁcant interaction between
Figure 3. Prenatal immune activation did not affect the acquisition and expression of contextual fear conditioning. (a) Intact acquisition of fear
conditioning in offspring born to PolyI:C-exposed (POL) or control (CON) mothers. The line plots show percent time freezing during the 30-s
post-shock bins on the day of conditioning, and the bar plots show the mean percent time freezing across the entire post-shock period. The
black arrowheads indicate the occurrence of the foot-shock stimulus. (b) Intact expression of contextual fear memory in POL and CON
offspring. The line plots display percent time freezing as a function of 30-s bins during the contextual memory test phase, and the bar plots
show the mean percent time freezing across the entire 6-min test period. N(CON)= 16, N(POL)= 16. All values are mean± s.e.m.
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prenatal treatment and bins (F(5,70) = 2.50, Po0.05). Subsequent
post hoc comparisons revealed signiﬁcant group differences at
several individual time points after cocaine treatment (all
Po0.05). Signiﬁcant group differences in locomotor activity were
only observed following cocaine, but not saline, administration
(Figure 4e). An additional analysis of the mean meanders (that is,
degrees of turn angle divided by distance moved) was performed
to assess behavioral patterning as an index of behavioral
stereotypy. These analyses revealed no group differences,
suggesting that the PolyI:C-induced differences in cocaine-
induced locomotor activity are not driven by altered locomotor
patterning (Supplementary Figure S1).
DISCUSSION
The present study demonstrates that prenatal exposure to viral-
like immune activation alters reward processing in contextual
preference tasks. Offspring of immune-challenged mothers
exhibited deﬁcits in the expression of sucrose CPP, whereas they
did not display alterations in the sucrose preference or neophobia
tests. These data thus suggest that prenatal immune activation
impairs the ability to adequately engage context–reward associa-
tions for natural reinforcers such as sucrose without changing
hedonic or neophobic responses to the reinforcer itself. Moreover,
the deﬁcits in sucrose CPP were not associated with any changes
in locomotor activity, so that the reward-related phenotype of
Figure 4. Prenatal immune activation enhanced context–reward associations elicited by cocaine. (a) Enhanced place preference for cocaine in
offspring born to PolyI:C-exposed (POL) as compared with control (CON) mothers. The line plots show exploratory time in the saline-paired (S)
and cocaine-paired (C) chamber as a function of 5-min bins during the test phase, and the bar plots show the total exploratory time in the two
chambers across the entire test period. **Po0.01 and ***Po0.001, based on post hoc comparisons in CON and POL offspring, respectively.
+Po0.05, signifying a signiﬁcant difference in the total exploratory time of the cocaine, and saline chambers, respectively, in POL as compared
with CON offspring; based on post hoc comparisons. (b) Enhanced place preference for cocaine in POL offspring as assessed by the relative
difference in the time spent in the cocaine- vs saline-paired chamber. #Po0.05, based on a one-way analysis of variance. (c) Intact locomotor
activity in POL and CON offspring during the place preference test phase. The line plots show the distance moved in both chambers as a
function of 5-min bins during the test phase, and the bar plots show the total distance moved in the two chambers. (d) Computer-generated
exploration patterns for representative POL and CON offspring in the two (saline- or cocaine-paired) chambers during the test phase. (e)
Reduced cocaine-induced locomotor responses in POL as compared with CON offspring during the conditioning phase of the test. The line
plots show the square-root-transformed distance moved as a function of 5-min bins in the saline- and cocaine-paired chambers on
conditioning days 1 and 2. *Po0.05, reﬂecting a signiﬁcant reduction in the locomotor response to cocaine in POL as compared with CON
offspring at individual time points. N(CON)= 18, N(POL)= 18. All values are mean± s.e.m.
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immune-challenged offspring is not secondary to aphasia or
fatigue. We also did not detect any differences in general food or
ﬂuid intake, suggesting that the effects demonstrated herein are
not secondary to differences in internal states such as hunger or
thirst. Rather, the present data suggest that prenatal immune
activation leads to abnormalities in the ability to translate
previously established context–reward associations into adequate
goal-directed exploratory behavior. In support of this notion, both
experimental treatment groups similarly displayed short latencies
to consume the sucrose solution on the last conditioning day,
indicating that the ability to create context–reward associations
appears to be intact in immune-challenged offspring. Our data
thus suggest that the PolyI:C-induced deﬁcits in sucrose CPP
cannot be attributed to primary defects in reinforcement learning
and/or incentive salience attribution, but may rather be pre-
cipitated by an inability to retrieve previously established context–
reward associations and to integrate such information for
appropriate goal-directed behavior.
A number of neuropsychological and cognitive processes could
underlie these effects. For example, they may involve impairments
in the capacity to reintegrate previously acquired information
about contexts (that is, two segregated chambers during
conditioning) into a novel contextual entity (one large chamber
made of two subchambers during the test day), a phenomena
known to rely on prefrontal–hippocampal functions.31 These
behavioral deﬁcits may also depend on the capacity to integrate
information about the value of actions and rewards, largely
dependent on orbitofrontal and striatal activity.39–41 The place
preference deﬁcits could also emerge as a result of altered
decision making when facing two competing choices, or as a
result of a reduced capacity for uncertainty-driven exploration.
The latter is characterized by the ability to generate exploratory
behaviors in environments where reward outcomes are uncertain.
Decision-making and uncertainty-driven exploration are both
largely dependent on the integrity of the prefrontal cortex.12,42
Finally, the reward deﬁcits described herein could be induced by
abnormal cortico-striatal functions that translate decisions into
actions, a process that is further modulated by contextually
relevant hippocampal signals.31 One limitation of our study is that
we did not attempt to identify the neuronal substrates of altered
reward processing following prenatal immune challenge. Several
previous investigations, however, have repeatedly demonstrated a
number of cellular and neurochemical abnormalities in reward-
relevant brain areas of immune-challenged offspring, including
reduced levels of dopamine and impaired expression of GABAer-
gic markers in hippocampal and prefrontal tissues24,26,43–45 and
deﬁcient dopamine receptor functions in prefrontal and striatal
regions.25,46–48 Future studies will be necessary to determine
whether neural abnormalities in these mesocorticolimbic and
hippocampal circuits may functionally contribute to the reward-
related deﬁcits emerging following prenatal immune challenge. It
will also be interesting to determine whether the effects of
prenatal immune activation extend to other neuropsychological
impairments of the reward domain such as, for example, incentive
motivation and exertion of effort.
Another main ﬁnding of the present study is that prenatal
immune activation also altered contextual learning for the
psychostimulant drug cocaine. Unlike in the natural reward
(sucrose) condition, however, offspring of immune-challenged
mothers showed enhanced place preference for the drug reward.
At the same time, immune-challenged offspring displayed
reduced cocaine-induced locomotor hyperactivity compared with
cocaine-treated control offspring. The analyses of locomotor
patterning further suggested that these effects represent genuine
effects on locomotor activity rather than possible differences in
stereotyped behavior. Moreover, the PolyI:C-induced effects on
cocaine CPP scores remained signiﬁcant after controlling for
differences in locomotor activity. Our ﬁndings thus reveal an
intriguing dissociation between the locomotor-enhancing effects
of cocaine and its reward-related properties, whereby reduced
locomotor activity in prenatally challenged offspring are con-
comitant to an enhancement of context–cocaine associations. Our
data are in line with the notion that the locomotor-stimulating
and reward-related effects of cocaine partly rely on distinct
neuronal mechanisms and brain subregions.49,50 Accordingly, the
attenuation of cocaine-induced hyperactivity may primarily
involve reduced dopamine transporter availability in the core
region of the nucleus accumbens, which mediates the immediate
locomotor effects of acute cocaine treatment.51–53 Conversely,
context–cocaine reward behaviors critically depend on integrated
circuits within hippocampal and cortico-striatal loops engaging
the nucleus accumbens shell, which together promote context–
drug learning, attribution of incentive and predictive properties to
contexts, and retrieval of memories.49,50,54,55 These processes
emerge after repeated context–cocaine pairings over several days,
which likely involves synaptic remodeling and plasticity-related
changes within mesocorticolimbic regions.56,57 For example, an
elegant study by Muñoz-Cuevas et al.56 identiﬁed rapid spine gain
in prefrontal pyramidal neurons following cocaine administration,
demonstrating that persistent new spines correlate with the
magnitude of cocaine place preference, but not with locomotor
sensitization to the drug. Enhanced neuroadaptive changes in
mesocorticolimbic structures, together with an overlearning of
drug-related cues,55 could thus provide a plausible explanation for
the increased cocaine place preference emerging in PolyI:C
offspring. Even though indirect evidence for this possibility exists
based on previous neurochemical and neuroanatomical
studies,25,46–48 future investigations will be required to delineate
the exact neural mechanisms implicated in these effects.
It also remains elusive whether the diametrically opposite
patterns of reward abnormalities (reduced and enhanced reward
responses to sucrose and cocaine, respectively) may arise from
defects in the same neural circuits, or rather whether they
represent independent pathological entities. According to some
theoretical accounts, however, seemingly contradictory reward-
related phenotypes, such as reduced place preference for sucrose
and enhanced place preference for cocaine, could indeed be
induced by mutual neural mechanisms. One of these mechanisms
may relate to abnormal tonic vs phasic dopamine signaling: it has
been hypothesized that abnormalities in tonic vs phasic dopami-
nergic signals could result in deﬁcient signal-to-noise
detectability.58 According to this theory, sucrose stimuli would
fail to elicit a sufﬁciently large phasic dopamine response to be
detected above ‘noise’ thresholds in immune-challenged
offspring,58–60 whereas cocaine may elicit stronger phasic signals
in immune-challenged offspring compared with controls.59,60 The
latter may occur because of the existence of abnormally large
phasic vs tonic dopamine responses to strong dopaminergic
stimulants such as cocaine (or cocaine-related cues), similarly to
what has been proposed in the context of the aberrant salience
hypothesis of schizophrenia.11,61,62
An alternative (but not mutually exclusive) explanation for the
differential effects of prenatal PolyI:C exposure on sucrose- and
cocaine-induced CPP relates to a recent observation suggesting
that exposure to natural and drug rewards induce partly distinct
neuronal changes, in particular within the prefrontal-to-
accumbens glutamate pathway and/or downstream medium
spiny neurons.63,64 For example, rat studies have shown that
cocaine exposure, but not food exposure, elicits prefrontal-
dependent increases in spine size and strength in accumbal
medium spiny neurons.65 In addition, a recent study has identiﬁed
differential expression of the epigenetic regulator MeCP2 and
some of its target genes (PP1Cβ or reelin) following passive- or
self-administration of cocaine vs food.66 In view of our ﬁndings, we
speculate that neurodevelopmental disruption by prenatal PolyI:C
exposure may differentially alter some of the key neuronal
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substrates underlying the rewarding effects of natural (for
example, sucrose) and drug (for example, cocaine) rewards, which
in turn may critically determine the direction of reward
abnormalities depending on the rewards’ nature.
Whatever precise mechanisms involved, our results are
consistent with and corroborate some of the reward-related
dysfunctions present in schizophrenia and other neurodevelop-
mental animal models relevant to this disorder. In line with our
observations in the sucrose preference test of anhedonia, patients
with schizophrenia typically retain the ability to enjoy pleasurable
stimuli.6,42 Furthermore, our results match the large body of
evidence suggesting that individuals with schizophrenia show
intact negative reinforcement learning, similarly to what we have
observed in the contextual fear conditioning test. On the other
hand, patients with schizophrenia display clear deﬁcits in
positively motivated learning tasks involving rewarding
stimuli.67,68 Besides other abnormalities, affected individuals seem
to be incapable of translating value/effort-related information into
goal-directed action.6 They also show difﬁculties in their ability for
uncertainty-driven exploration.12,42 Both of these deﬁcits seem to
critically involve prefrontal dysfunctions, which we believe might
be implicated in the sucrose place preference deﬁcits that
emerged following prenatal immune activation.
It is also interesting to note that several studies have reported a
high prevalence of substance use disorder in schizophrenia,
including abuse of psychostimulant drugs such as cocaine.69,70
The ﬁndings from our preclinical model suggests that maternal
infection could represent one of the neurodevelopmental factors
triggering the appearance of an addiction-prone phenotype in
patients with schizophrenia, although epidemiological data
supporting such an association are missing thus far. Yet, our
ﬁndings are in line with the previous work in other schizophrenia-
relevant animal models documenting altered responses to natural
or drug rewards, including models that are based on neonatal
ventral hippocampal lesion,71–73 prenatal infection74,75 or mutant
expression of DISC1.76 Altogether, these observations provide
support for the theory that the predilection for addictive behavior
would be ingrained in schizophrenia neuropathology.77 Indeed, it
has been proposed that the neuropathological abnormalities that
emerge in the brain of individuals with schizophrenia across
neurodevelopment create a state of ‘endogenous sensitization’, so
that functional hyper-responsiveness of dopamine-related circuits,
coupled with reduced inhibitory control arising from cortical
structures (some of the hallmark features of schizophrenia), could
result in a hypersensitivity to the rewarding effects of drugs.77,78
Although current knowledge does not readily allow conﬁrming or
refuting this hypothesis, our ﬁndings support the notion that
neurodevelopmental changes in mesocorticolimbic circuits, which
emerge in response to prenatal immune challenge, could
potentially also be responsible for drug-related behavioral
abnormalities.
As extensively reviewed elsewhere,18,19 the prenatal PolyI:C
administration model in rodents is characterized by substantial
face, construct and predictive validity, and it bares epidemiologi-
cal relevance to schizophrenia and related disorders. As with many
other preclinical models of schizophrenia, however, the PolyI:C
model has thus far only received scant attention with respect to
modeling aspects relevant to the negative symptoms of
schizophrenia.26,27 Given the necessity to establish effective
therapeutic interventions against negative symptoms,3,4 efforts
to develop and characterize preclinical models with relevance to
this symptom domain are urgently needed.27 The present study
may help in achieving this goal by extending the prenatal PolyI:C
administration model to reward-related phenotypes that are
reminiscent of key features of the negative symptomatology.
Together with other models, the PolyI:C model may also help to
address the question of whether reward deﬁcits are primary
pathological features of schizophrenia, or whether they emerge as
a consequence of pharmacotherapy. Although antipsychotic
drugs can affect reward-related functions,9 this class of symptoms
has also been documented in unmedicated patients with
schizophrenia.14 Given the known impact of prenatal PolyI:C
exposure on early neurodevelopmental processes and subsequent
brain maturation,18,19 our study provides preclinical evidence for
the hypothesis that at least some reward deﬁcits typically seen in
individuals with schizophrenia could arise as a pathological
consequence of neurodevelopmental insults during pregnancy,
such as those elicited by maternal infection.
Related to this, our ﬁndings may highlight a possible etiological
association linking maternal infection to substance abuse disorder
and/or dual diagnosis schizophrenia. Moreover, they may have
implications for the development of reward-related pathologies
independently of existing diagnostic classiﬁcations. In fact,
immune-mediated reward deﬁcits, such as those described in
the present study, could represent an intermediary phenotype
with relevance to various neuropsychiatric disorders characterized
by reward abnormalities, including autism,79 bipolar disorder80
and schizophrenia.6 According to this scenario, the adverse effects
of maternal immune activation on reward-related behaviors could
represent a point of entry into a disturbed reward system, whereas
the speciﬁcity of subsequent disease would be further inﬂuenced
by additional genetic or environmental factors. This hypothesis
would be in line with the emerging evidence suggesting that
maternal infection has an etiological role in a variety of
neuropsychiatric and neurological disorders with seemingly
remote pathologies.81,82 Against these backgrounds, our ﬁndings
may encourage future epidemiological studies to determine
whether prenatal infection increases the risk of developing
discrete neuropsychopathological features (such as reward-
related abnormalities) independently of existing diagnostic
classiﬁcations. Attempts toward this direction are limited to a
few studies showing that serologically documented prenatal
infection or inﬂammation is associated with the presence of
discrete neuroanatomical or neurocognitive dysfunctions in
patients with schizophrenia.83,84
In conclusion, our study demonstrates abnormal context–
reward associations in an immune-mediated neurodevelopmental
mouse model relevant to schizophrenia and related disorders.
These deﬁcits likely stem from an inability to retrieve previously
established context–reward associations and to integrate such
information for appropriate goal-directed behavior, but not from
anhedonia, neophobia or primary defects in reinforcement
learning and/or incentive salience attribution. As currently
available pharmacotherapies have thus far failed to improve
reward-related deﬁcits in schizophrenia, our epidemiologically
informed mouse model may provide an important preclinical
platform for the establishment and characterization of novel
therapeutic intervention against these symptoms.
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